Search clinical trials for: Angiotensin Receptor Blockers

Total 21071 results

Emory University

Completed

A Retrospective Analysis of the Use of ACE-inhibitors and Angiotensin Receptor Blockers

Atrial Fibrillation | Atrial Flutter

United States
Hospital Authority, Hong Kong

Unknown

Effect of Renin-angiotensin System Blockers on Glomerular Filtration Rate in Patients With Hypertension, Type 2 Diabetes With Normoalbuminuria (eGFR)

Diabetes | Hypertensive Disease

China
The Affiliated Hospital of Qingdao University

Recruiting

A Bioequivalence Trial of Irbesartan Tablets（0.15g） in Healthy Chinese Subjects

Bioequivalence | Irbesartan Tablets (0.15g/Tablet) | Under Fasted Condition | Under Fed Condition

China
Samsung Medical Center

Recruiting

Strain vs. Left Ventricular Ejection Fraction-based Cardiotoxicity Prevention in Breast Cancer

Breast Cancer | Cardiotoxicity | Prevention | Adjuvant | Trastuzumab

Korea, Republic of
Shanghai Pharmaceuticals Holding Co., Ltd

Completed

Study to Evaluate the Efficacy and Safety of SPH3127 In Patients With Mild-moderate Essential Hypertension

Essential Hypertension

China
Mayo Clinic
National Heart, Lung, and Blood Institute (NHLBI)

Completed

CR Aim #2 - AT1 Receptor Blockade & ACE Inhibition Effect on Humoral Function

Cardiorenal Syndrome (CRS)

United States
Takeda

Completed

Azilsaltan Tablets (Azilva Tablets) Special Drug Use Surveillance "Hypertension Complicated by Diabetes "

Hypertension

Japan
Boehringer Ingelheim

Completed

J-TARGET,Japanese Telmisartan Study for Antihypertensive Good Effect in Long Term Observation

Hypertension
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Valsartan 320mg Tablets Under Fasting Conditions

Healthy

India
Boehringer Ingelheim

Completed

Safety, Tolerability and Efficacy of Micardis® in Patients With Essential Hypertension

Hypertension
AstraZeneca
Takeda

Completed

DIabetic Retinopathy Candesartan Trials (DIRECT)

Type 2 Diabetes
National Taiwan University Hospital
Daiichi Sankyo Taiwan Ltd.

Completed

Evaluation of Effects of Exercise Training and ARB in DM Patients

Exercise Training | Vascular Function

Taiwan
Novartis

Completed

Effect of Valsartan on Proteinuria in Patients With Hypertension and Diabetes Mellitus

Hypertension | Type 2 Diabetes | PROTEINURIA
Novartis

Completed

Efficacy and Safety of Fluvastatin or Valsartan and Their Combination in Dyslipidemic Patients With Hypertension and Endothelial Dysfunction

Hypertension | Dyslipidemia

Russian Federation
Novartis

Completed

8 Weeks Study to Evaluate the Efficacy and Safety of Valsartan in Combination With Aliskiren Compared to Valsartan Alone in Patients With Stage 2 Hypertension (VANTAGE)

Stage 2 Hypertension

United States
AstraZeneca

Completed

Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Added)

Congestive Heart Failure
Gruppo di Ricerca GISSI

Completed

GISSI-AF - Use of Valsartan an Angiotensin II AT1-Receptor Blocker in the Prevention of Atrial Fibrillation Recurrence

Atrial Fibrillation

Italy, Switzerland
Novartis Pharmaceuticals

Terminated

A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril

Hypertension | Diabetic Nephropathy

Switzerland
Technische Universität Dresden

Completed

Characterization of Vascular Effects of Angiotensin II in Dorsal Human Hand Veins.

Healthy Subjects

Germany
Celltrion Pharm, Inc.

Completed

A Study for PMS of AZL-M in the Treatment of Adult Participants With Essential Hypertension in South Korea

Essential Hypertension

Korea, Republic of
Jiangsu HengRui Medicine Co., Ltd.

Unknown

The DDI Study of SP2086 and Valsartan

Type 2 Diabetes

China
Takeda

Completed

A Phase 1 Food Effect Study of TAK-536TCH Final Formulation Tablet

Hypertension

Japan
LG Life Sciences

Completed

Pharmacokinetic Drug Interaction Study Between Gemigliptin and Irbesartan After Oral Administration in Healthy Male Subjects

Healthy

Korea, Republic of
University of California, Los Angeles
The Campbell Foundation

Completed

A Clinical Trial for People HIV+ Age > 50 at Risk for Heart Disease

Endothelial Dysfunction

United States
Novartis

Completed

To Find Out Whether Valsartan With or Without Other Blood Pressure Medications Would Improve the Ability of the Heart to Fill and Empty, and the Ability of the Heart Muscle to Relax Adequately in People With High Blood Pressure.

Hypertension | Diastolic Dysfunction

United States
Samsung Medical Center

Unknown

The Change of Urinary Angiotensinogen Excretion After Valsartan Treatment in Patients With Persistent Proteinuria

Proteinuria | Chronic Kidney Disease

Korea, Republic of
Charles University, Czech Republic
AstraZeneca

Unknown

CHANCE - Candesartan in Hypertrophic Cardiomyopathy

Hypertrophic Cardiomyopathy

Czech Republic
Asker & Baerum Hospital
Ullevaal University Hospital; AstraZeneca; Helse Ost

Completed

Candesartan in the Prevention of Relapsing Atrial Fibrillation

Atrial Fibrillation

Norway
Karolinska University Hospital
AstraZeneca

Unknown

Diabetes Type 1, Treatment Study Atacand/Placebo After Kidney Biopsy

Diabetes, Type I

Sweden
Medical University Innsbruck
Ludwig-Maximilians - University of Munich; Deutsches Zentrum für Herz-Kreislauf-Forschung...

Completed

Stopping ACE-inhibitors in COVID-19 (ACEI-COVID)

COVID-19 | SARS-CoV-2

Germany, Austria
D'Or Institute for Research and Education
Brazilian Clinical Research Institute

Unknown

Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Patients With COVID19 (BRACE-CORONA)

COVID-19 | Corona Virus Infection

Brazil
Sherief Abd-Elsalam

Recruiting

Statins and ARBs on Rheumatoid Activity

Rheumatoid Arthritis

Egypt
Fifth Affiliated Hospital, Sun Yat-Sen University
Third Affiliated Hospital, Sun Yat-Sen University

Not yet recruiting

Nighttime Valsartan in Hemodialysis Hypertension (NVHH)

Hypertension;Nephropathy
Emory University
National Institute on Aging (NIA)

Completed

Candesartan's Effects on Alzheimer's Disease And Related Biomarkers (CEDAR)

Mild Cognitive Impairment

United States
Children's Hospital Medical Center, Cincinnati

Completed

Losartan to Reverse Sickle Nephropathy

Sickle Cell Anemia | Nephropathy

United States
Takeda

Completed

International Multicenter, Observational, Non-Interventional Prospective Study of Azilsartan Medoxomil in Participants With Arterial Hypertension Who Are Overweight or Obese in the Russian Federation and The Republic of Kazakhstan

Hypertension

Russian Federation, Kazakhstan
Takeda

Completed

Azilsartan Medoxomil in the Treatment of Essential Hypertension and Type 2 Diabetes in Asia

Type 2 Diabetes Mellitus | Essential Hypertension

Taiwan, Thailand, China
Wake Forest University Health Sciences
Johns Hopkins University

Terminated

Angiotensin Receptors and Age Related Mitochondrial Decline in HIV Patients (RAS-HIV)

HIV | Sarcopenia | Aging | Angiotensin Receptor Antagonists

United States
Mitsubishi Tanabe Pharma Corporation

Completed

Drug-Drug Interaction Study to Evaluate the Effect of Colestilan on the Pharmacokinetics of Single Doses of Candesartan Cilexetil in Healthy Subjects

Chronic Kidney Disease | Hyperphosphatemia

United Kingdom
Boehringer Ingelheim

Completed

Study to Evaluate Efficacy of Micardis® (Telmisartan) and Valsartan in Patients With Mild-to-moderate Hypertension After Missing One Dose Using Ambulatory Blood Pressure Monitoring

Hypertension
Boehringer Ingelheim

Completed

Post-Marketing Surveillance Study of Micardis® Plus in Patients With Hypertension

Hypertension
Boryung Pharmaceutical Co., Ltd
Asan Medical Center; Chonnam National University Hospital; Seoul National University... and other collaborators

Completed

A Valsartan 80 Mg-Referenced, Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan 30 mg During 24 Hours in Patients With Mild to Moderate Essential Hypertension

Essential Hypertension

Korea, Republic of
AstraZeneca

Completed

Efficacy Observational Study of Candesartan Cilexetil on Hypertensive Patients

Primary Hypertension

Romania
Uppsala University
Karolinska Institutet; Oslo University Hospital; Göteborg University; New York... and other collaborators

Terminated

Randomized Evaluation of Beta Blocker and ACEI/ARB Treatment in MINOCA Patients - MINOCA-BAT (MINOCA-BAT)

Myocardial Infarction With Non-obstructive Coronary Arteries

Norway, Sweden, Australia, New Zealand, Spain
University of Hawaii
National Institute on Minority Health and Health Disparities (NIMHD)

Terminated

Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Mitigation of Pulmonary and Cardiac Complications in COVID-19 Patients

COVID-19

United States
Xiaoduo Fan

Terminated

Telmisartan Pilot Study on Treatment Resistant Schizophrenia

Schizophrenia | Schizo Affective Disorder | Treatment-resistant Schizophrenia

United States
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Telmisartan to Reduce AIDS-Related Fibrotic and Inflammatory Contributors (TRAFIC Study) (TRAFIC)

HIV-1 Infection

United States, Puerto Rico
Yale University
National Institute of Mental Health (NIMH); National Institute of Neurological... and other collaborators

Completed

Analysis of Telmisartan Administered With Antiretroviral Therapy (ART) in Patients With Acute HIV Infection (SEARCH018)

HIV Infections | Acute HIV Infection

Thailand
University of Chicago
Takeda

Completed

Effect of Azilsartan on Aldosterone in Postmenopausal Females

Hypertension

United States
National Institute of Allergy and Infectious Diseases...

Withdrawn

Optimal Treatment for Kidney Disease in HIV Infected Adults

HIV Infections | Kidney Disease

United States

3

Subscribe